Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BENFNASDAQ:LMFANASDAQ:NRBONASDAQ:SAIH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBENFBeneficient$0.28+1.1%$0.31$0.22▼$13.00$2.45M-0.952.03 million shs74,003 shsLMFALM Funding America$1.66+11.4%$1.35$1.02▼$6.11$8.52M1.4799,442 shs57,827 shsNRBONeuroBo Pharmaceuticals$0.76-2.4%$1.34$2.08▼$5.30$6.56M-0.2649,174 shs78,516 shsSAIHSAIHEAT$6.36+0.5%$5.92$3.00▼$26.98$6.11M2.0238,931 shs100,703 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBENFBeneficient+0.36%+11.46%-10.43%-56.04%-91.57%LMFALM Funding America-2.61%+12.03%+20.16%-23.98%-39.19%NRBONeuroBo Pharmaceuticals-1.38%+4.01%-50.47%-60.60%-76.36%SAIHSAIHEAT-16.93%+30.79%+46.87%-51.21%+632,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBENFBeneficient2.1326 of 5 stars0.05.00.00.02.63.30.6LMFALM Funding America2.1233 of 5 stars0.05.00.00.03.01.71.3NRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ASAIHSAIHEATN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBENFBeneficient 0.00N/AN/AN/ALMFALM Funding America 2.00HoldN/AN/ANRBONeuroBo Pharmaceuticals 3.00Buy$10.001,214.06% UpsideSAIHSAIHEAT 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest BENF, LMFA, SAIH, and NRBO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/2/2025LMFALM Funding AmericaHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBENFBeneficient-$20.08M-0.12N/AN/AN/A∞LMFALM Funding America$16.99M0.50N/AN/A$15.97 per share0.10NRBONeuroBo PharmaceuticalsN/AN/AN/AN/A$1.50 per shareN/ASAIHSAIHEAT$6.95M0.88N/AN/A$1.17 per share5.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBENFBeneficientN/AN/A0.00N/AN/AN/AN/AN/A7/8/2025 (Estimated)LMFALM Funding America-$15.94M-$5.10N/AN/AN/A-96.23%-35.84%-31.86%5/15/2025 (Estimated)NRBONeuroBo Pharmaceuticals-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%5/7/2025 (Estimated)SAIHSAIHEAT-$6.12MN/A0.00∞N/AN/AN/AN/AN/ALatest BENF, LMFA, SAIH, and NRBO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025LMFALM Funding America-$0.65N/AN/AN/A$2.85 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBENFBeneficientN/AN/AN/AN/AN/ALMFALM Funding AmericaN/AN/AN/AN/AN/ANRBONeuroBo PharmaceuticalsN/AN/AN/AN/AN/ASAIHSAIHEATN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBENFBeneficientN/AN/AN/ALMFALM Funding America0.173.653.65NRBONeuroBo PharmaceuticalsN/A2.412.41SAIHSAIHEATN/A7.067.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBENFBeneficient90.57%LMFALM Funding America22.73%NRBONeuroBo Pharmaceuticals1.37%SAIHSAIHEAT0.16%Insider OwnershipCompanyInsider OwnershipBENFBeneficient13.69%LMFALM Funding America36.14%NRBONeuroBo Pharmaceuticals1.05%SAIHSAIHEATN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBENFBeneficient808.66 million7.47 millionNot OptionableLMFALM Funding America85.13 million3.28 millionNo DataNRBONeuroBo Pharmaceuticals108.62 million8.53 millionNot OptionableSAIHSAIHEAT37961,000N/AN/ABENF, LMFA, SAIH, and NRBO HeadlinesRecent News About These CompaniesSAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024April 28 at 4:30 PM | globenewswire.comSAIHEAT Limited Initially Covered by uSMART Securities | SAIH Stock NewsApril 23, 2025 | gurufocus.comSAIHEAT Limited Initially Covered by uSMART SecuritiesApril 23, 2025 | gurufocus.comSAIHEAT Limited Launches Initial Equity Research Report Coverage by uSMART SecuritiesApril 23, 2025 | quiverquant.comSAIHEAT Limited Initially Covered by uSMART SecuritiesApril 23, 2025 | globenewswire.comSAIHEAT Limited Regains Nasdaq Compliance After Bid Price RecoveryApril 14, 2025 | tipranks.comSAIHEAT Secures Major Liquid-Cooling Container Deal with BitdeerMarch 31, 2025 | tipranks.comSAIHEAT Announces Joining 1CP Program to Optimize Energy Costs for Bitcoin MiningMarch 27, 2025 | globenewswire.comSAIHEAT Limited Announces Effective Date of Reverse Stock SplitMarch 11, 2025 | globenewswire.comSAIHEAT Limited Announces Adoption of Shareholder Proposals at Extraordinary General MeetingMarch 4, 2025 | quiverquant.comSAIHEAT Limited Announces Results of Extraordinary General MeetingMarch 4, 2025 | globenewswire.comSAIHEAT Limited to Hold Extraordinary General Meeting on February 26, 2025February 18, 2025 | globenewswire.comSAIHEAT Limited Appoints Alexandre Nakata Ezzidi as Nuclear Energy Strategy ConsultantJanuary 24, 2025 | quiverquant.comSAIHEAT Announces Appointment of Alexandre Nakata Ezzidi as Nuclear Energy Strategy ConsultantJanuary 24, 2025 | globenewswire.comSAIHEAT Purchases $1.5 Million of BitcoinNovember 21, 2024 | globenewswire.comSAIHEAT Limited Announces Acceptance of Bitcoin Payments for Products and ServicesNovember 20, 2024 | quiverquant.comSAIHEAT Starts Accepting Payments in BitcoinNovember 20, 2024 | globenewswire.comSAIHEAT Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2024November 13, 2024 | globenewswire.comSAIHEAT Announces Bitcoin (BTC) Operations and Holding UpdatesNovember 12, 2024 | globenewswire.comSAIHEAT Introduces HEATNUC: An Open-Source Small Modular Reactor (SMR) Solution for AI Computing CentersNovember 11, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBENF, LMFA, SAIH, and NRBO Company DescriptionsBeneficient NASDAQ:BENF$0.28 +0.00 (+1.07%) Closing price 04:00 PM EasternExtended Trading$0.28 +0.00 (+0.35%) As of 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements. It also provides Ben Liquidity, which offers alternative asset liquidity and fiduciary financing products; Ben Custody that provides custody and trust administration services to trustees and document custodian services to customers; and Ben Markets, which provides broker-dealer and transfer agency services. In addition, the company provides Ben Insurance Services, which offers insurance products and services; and Ben Data that provides data collection, evaluation, and analytics products and services. It serves individual and institutional investors, wealth advisors, and general partners. Beneficient is based in Dallas, Texas.LM Funding America NASDAQ:LMFA$1.66 +0.17 (+11.41%) Closing price 03:59 PM EasternExtended Trading$1.66 0.00 (0.00%) As of 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LM Funding America, Inc. operates as a cryptocurrency mining and specialty finance company. It operates through two segments, Specialty Finance and Mining Operations. The company also engages in Bitcoin mining operations; and provides funding to nonprofit community associations. The company was founded in 2008 and is based in Tampa, Florida.NeuroBo Pharmaceuticals NASDAQ:NRBO$0.76 -0.02 (-2.45%) As of 04/30/2025NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.SAIHEAT NASDAQ:SAIH$6.36 +0.03 (+0.47%) Closing price 04:00 PM EasternExtended Trading$6.56 +0.21 (+3.22%) As of 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SAIHEAT Limited engages in the development of liquid-cooling data centers. It develops technologies for the advanced computing center ecosystem, a center that provides high-performance servers, liquid cooling, and systems for capturing and recycling computing heat. The company was formerly known as SAI.TECH Global Corporation and changed its name to SAIHEAT Limited in August 2024. SAIHEAT Limited was founded in 2019 and is headquartered in Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Crushes Earnings, What’s Next for MSFT Stock? McDonald’s Insiders Sell Shares! Investors Should Do the Opposite Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay Away Broadcom: Buy, Hold, Sell? AI & Acquistions Paint Strong Picture Hershey Hits the Sweet Spot for Defensive Investors A Bull Case for Adobe Stock Remains Today AMD Stock Signals Strong Buy Ahead of Earnings BigBear.ai: A Short-Squeeze Is Possible, a Sharp Drop Is Likely Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
